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significance was not reached. 
 
Conclusion  
MLC plans offer equivalent coverage and OAR dose sparing 
when compared to IRIS plans for Liver SBRT. An 
improvement in dose gradient was observed for MLC 
plans.MLC provided more efficient delivery with a 
significant reduction in treatment time. The need to 
prescribe to higher isodose levels when using MLC, 
requires, however, further investigation.  
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Purpose or Objective  
The aim of this study is to compare treatment plans 
optimized by dose volume objectives (DVO) to plans 
optimized with radiobiological objectives (RBO) or 
optimized by combining both DVO and RBO (Mixed) 
Material and Methods  
14 patients with prostate cancer previously treated with 
IMRT plans (Treatment Planning System: Pinnacle3) 
optimized by Dose Volume Objectives (DVO), were re-
planned by radiobiological optimization of gEUD objective 
functions (RBO) and using combined DVO and RBO, (Mixed 
Objectives). The prescribed dose to the target of patients 
varies between 70-78 Gy, delivered in 2 Gy/fraction. The 
plans were evaluated by dose volume indices (Conformity 
Index, CI, for PTV and D1%, D15%, D25% and D40% for both 
rectum and bladder, where Dx is the Dose received by x% 
of the volume of the OAR) and by radiobiological indices 
(TCP, NTCP and complication free control probability P+). 
The Poisson\LQ model and Kallman s-model were used in 
calculation of TCP and NTCP, respectively. 
Results  
The mean and standard deviation (SD) values of TCP for 
DVO, RBO and Mixed objectives plans were 0.914±0.05, 
0.895±0.07 and 0.912±0.06 respectively. Mean and SD 
values for NTCP were 0.0413±0.03, 0.0387±0.02 and 
0.0365±0.03 for DVO, RBO and Mixed respectively, while 
P+ mean and SD values for the three objective techniques 
were 0.872±0.06, 0.8557±0.07 and 0.874±0.05, 
respectively. The mean value of CI of PTV and D40% for 
rectum and bladder were 0.805±0.08, 34±0.18Gy, 28±0.6 
Gy for DVO, 0.739±0.11, 21.4±0.27 Gy, 21.7±0.72 Gy for 
RBO and 0.853±0.045, 25.9±0.22 Gy, 22.6±0.72 Gy for 
mixed objectives. 
Conclusion  
For OAR mean dose values we found that RBO gives the 
lowest doses compared to both DVO and mixed plans, 
while TCP values in DVO and Mixed plans were better than 
RBO. DVO and Mixed plans provide comparable TCP values 
while RBO gives the lowest TCP values. As to CI, Mixed 
plans win over both DVO and RBO. In conclusion, by using 
mixed radiobiological and dose-volume objectives it 
improves the conformity to the target and also NTCP of 
the plan, giving at the same time a comparable TCP as 
DVO  plans. 
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Purpose or Objective  
Proton therapy for prostate cancer has the potential of 
delivering high dose to the tumor whilst sparing normal 
tissue to minimize GI/GU toxicity. In the traditional PTV-
based multifield optimized intensity modulated proton 
therapy (MFO-IMPT) approach to treatment planning for 
prostate cancer, the PTV is commonly defined through 
expansion of the CTV to account for setup and range 
uncertainties. In contrast to this method, the robust 
optimization approach to IMPT planning does not require 
the intermediate and somewhat arbitrary step of defining 
the PTV. Instead, the optimizer is tasked with finding a 
treatment plan which best meets the clinical objectives 
under the setup and beam range uncertainties which are 
explicitly expressed as the input parameters to the 
treatment planning process. The goal of this study was to 
apply the robust optimization method for IMPT treatment 
planning for prostate cancer and evaluate the results 
against the traditional PTV-based IMPT treatment planning 
strategy. 
Material and Methods  
For five T1-3N0M0 prostate cancer patients two types of 
MFO-IMPT treatment plans were created in Raystation 
4.99 (RaySearch Laboratories AB, Sweden) treatment 
planning system: a PTV-based plan and a robustly 
optimized CTV-based plan. The PTV margin for CTV70 was 
defined as 5 mm in all directions. The robustness 
parameters for the robust optimization were set to 5 mm 
and 3% for setup translational uncertainty and range 
uncertainty, respectively, and the optimization was 
performed using the ‘minimax’ method implemented in 
Raystation. Treatment plans were normalized to D98% of 
the CTV77. The plans were evaluated for robustness by 
simulating translational and rotational setup errors of the 
planning CT by ±5 mm and ±2⁰  (yaw and roll), 
respectively. In addition, the range uncertainty was 
simulated by scaling the HU of the planning CT by ±3%. By 
combining the above robustness evaluation modes a total 
of 260 dose scenarios per plan was obtained. The target 
coverage robustness was assessed by comparing the 
voxelwise-minimum (a metric constructed by finding a 
minimum value of dose in each voxel independently for all 
the dose scenarios) and average V95% of the CTV70. To 
compare dose to the rectum, the entire DVH of the rectum 
was evaluated for the nominal dose as well as the 
voxelwise-maximum dose. 
Results  
The V95% of the CTV70  calculated from  the voxelwise-
minimum DVHs were consistent (>99%). Also, the average 
V95% over all dose scenarios of the CTV70 were comparable 
(>99%). The benefit of the robust treatment planning 
approach was apparent for the rectum dose where the 
dose is lower for the robustly optimized plan in both the 
nominal as well as in the perturbed dose scenarios 
(nominal and voxelwise-maximum dose presented in 
Figure 1). Only for doses >70 Gy, the CTV-based plans 
resulted in a slightly higher irradiated rectum volume than 
the  PTV-based  plans. 
 







The CTV-based robustly optimized treatment plans 
maintain target coverage, while providing a lower dose to 
the  rectum. 
   
EP-1553  Dose reduction of femoral heads using 
volumetric-modulated Dynamic WaveArc for prostate 
cancer 
K. Nakamura1, T. Mizowaki1, M. Uto1, N. Mukumoto1, Y. 
Miyabe1, T. Ono1, H. Hirashima1, K. Yokota1, H. Hiraoka1 
1Kyoto University- Graduate School of Medicine, Radiation 
Oncology and Image-Applied Therapy, Kyoto, Japan 
 
Purpose or Objective  
Although hip fracture is a rare complication in radiation 
therapy for prostate cancer (PCa), it is a major cause of 
morbidity and mortality in elderly patients. Therefore, the 
femoral heads are the major organs at risk (OARs) in 
treatment planning of PCa and reduction of doses to the 
femoral heads could be important. A new irradiation 
technique, termed volumetric-modulated Dynamic 
WaveArc (DWA), has been developed. Figure 1 shows the 
trajectory of DWA beam. An X-ray head with multileaf 
collimators mounted on an O-ring gantry allows combining 
simultaneous rotation of the gantry and O-ring, resulting 
in sequential noncoplanar intensity-modulated beam 
delivery in a short treatment time, without a couch 
rotation. Since the bilateral femoral heads were located 
on the same level as the planning target volume (PTV) in 
PCa patients, DWA would reduce the doses to the bilateral 
femoral heads. We performed a planning study using 
coplanar volumetric-modulated arc therapy (coVMAT) and 
DWA to compare the dose distribution of PTV and OARs, 
beam-on time, and monitor units (MU).
 
Material and Methods  
The coVMAT and DWA plans were created for 20 patients 
with PCa respectively using RayStation version 4.7 and 
Vero4DRT. All plans were created using one full arc and 
the prescribed dose was 76 Gy in 38 fractions as a mean 
dose to PTV. We compared the dose distributions of OARs 
(bilateral femoral heads, rectal wall, and bladder wall) 
and PTV, beam-on time, and MU using a paired t test, and 
a significance level of less than 5% (p < 0.05) was 
considered statistically significant. 
Results  
Table 1 shows the plan comparison between coVMAT and 
DWA. The mean doses and D1cc of the bilateral femoral 
heads in coVMAT/DWA plans were 11.8/9.1 Gy (p < 0.001) 
and 21.8/18.5 Gy (p < 0.001), respectively. Although the 
mean volume of bladder wall irradiated greater than 10, 
20, 30 and 40 Gy (V10-40) were significantly larger in DWA 
plans compared with coVMAT, the mean volume of rectal 
wall irradiated greater than 10, 20, and 70 Gy (V10, V20, 
and V70) were significantly smaller in DWA plans. The 
conformity index and homogeneity index were similar in 
both plans. The mean beam-on time and MU in 
coVMAT/DWA plans were 70.6/73.5 seconds (p = 0.045) 
and 427/454 MU (p = 0.041), respectively.
 
 
 
